Anavex Life Sciences is a clinical-stage biopharmaceutical company developing oral therapies for neurodegenerative and neurodevelopmental diseases.
Meet Anavex’s executive leadership and scientific advisors, whose experience in drug development, clinical research, and regulatory science guides the Company’s strategic direction.
Dr. Missling, President and CEO of Anavex, has over 20 years of healthcare industry experience within large pharmaceutical companies, the...
Prof. Dr. Marwan Sabbagh, MD, is a behavioral neurologist in the Alzheimer’s and Memory Disorders Program at Barrow Neurological Institute....
Juan Carlos Lopez-Talavera, MD, PhD, brings over 20 years of leadership experience in managing registrational clinical trials and advancing patient...
Prof. Dr. Grimmer is a board-certified psychiatrist and psychotherapist and an Associate Professor working as a Specialist Registrar at the...
Steffen Thomas, PhD, has over 15 years of experience as a European patent attorney and is currently practicing at Epping...
Wolfgang Liedtke, MD, PhD, Senior Vice President, Global Head of Neurology, is a board-certified neurologist who brings more than 25...
At Anavex Life Sciences, our work is driven by rigorous research, cross-functional collaboration, and a shared commitment to addressing unmet medical needs. We bring together scientists, clinicians, and professionals across disciplines to support the development of innovative oral therapeutic programs.
We recognize that disease progression and treatment response vary across individuals. Our research and development approach emphasizes precision strategies designed to address underlying biological mechanisms and patient variability.
Patients and caregivers provide essential insight into disease impact and treatment priorities. We value collaboration with patient communities and integrate real-world perspectives into our research and development process.
Our development programs are grounded in translational science and supported by data-driven decision-making across discovery, clinical research, and regulatory pathways.
We are committed to fostering an inclusive workplace and supporting the development of therapies intended to serve diverse patient populations worldwide.
Toll-free: 1 (844) 689-3939
ir@anavex.com
media@anavex.com
